Rejuvenating the gut: young plasma therapy improves cell proliferation, IGF-I and IGF-IR expression, and immune defense in aged male rats jejunum

Abstract

It is well known that aging affects many systems in the body. The digestive system is one of the systems most affected by aging. In our study, we examined the effects of young plasma treatment on cell proliferation, growth factors, immune defense and histological parameters in the jejunum of aged male rats. For this purpose, aged male Sprague Dawley rats (24 months, n = 7) were treated with pooled plasma (0.5 ml/day, intravenously for 30 days) collected from young (5 weeks, n = 51) rats. Aged rats that received young plasma treatment were grouped as the experimental group, while aged rats formed the control group. At the end of the experiment, the jejunums of the groups were collected and histological parameters such as villus height, crypt depth, total mucosal thickness and surface absorption areas were measured and compared. In addition, cell proliferation index and proliferation intensity in the crypt glands of the jejunum were evaluated with proliferating cell nuclear antigen and expressions of growth factors such as insulin-like growth factor I (IGF-I) and its receptor (IGF-IR) expression and effects of immunoglobulin A (IgA), which plays a role in the defense of the digestive system against microorganisms, were examined. In the experimental group, an increase in histological parameters, IGF-R and IGF-IR expression, proliferation density, proliferation index and IgA expression density and IgA cell count were observed compared to the control group. These results suggest that young plasma treatment has a positive effect on the digestive system and may be a potential therapeutic for tissue regeneration.

Keywords: IGF-I; IGF-IR; IgA; Jejunum; Proliferation; Young plasma.

Fig. 1

Morphometric analysis of jejunum in experimental and control groups. a–b Villus height, b–c crypt depth, a–c total mucosal thickness (Bar: 50 µm)

Fig. 2

IGF-I expression in the jejunum of control and experimental groups. Arrowhead: IGF-I positive immunoreaction, arrow: IGF-I negative immunoreaction. (Bar: 50 µm)

Fig. 3

IGF-IR expression in the jejunum of control and experimental groups. Arrowhead: IGF-I positive immunoreaction, arrow: IGF-IR negative immunoreaction. (Bar: 50 µm)

Fig. 4

IgA expression in the jejunum of control and experimental groups. Arrowhead: IgA positive cells, arrow: IgA negative cells. (Bar: 50 µm)

Fig. 5

PCNA expression intensity in experimental and control groups. Arrowhead: IgA positive cells, arrow: IgA negative cells. (Bar: 50 µm)

Fig. 6

Negative control groups for PCNA, IgA, IGF-I and IGF-IR (Bar: 50 µm)